UNSPSC 85512525: Bypass abdominal aorta to left external iliac artery with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass abdominal aorta to left external iliac artery with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04100KF

UNSPSC 85512525, Bypass abdominal aorta to left external iliac artery with nonautologous tissue substitute, open approach, is a Commodity code that appears misaligned with the recent state and local procurement activity tagged under it. The code nominally describes a specific surgical procedure, yet the recent opportunities posted under this code solicit occupational health examinations, pharmacy benefit management, specialty surgical networks through Centers of Excellence, independent medical evaluations for pension disability determinations, emergency and specialty care for detained youth, and temporary health professional staffing across ancillary clinical categories — none of which represent performance of that particular bypass procedure. The source contains no evidence that state and local governments are soliciting aortic bypass surgery as a commodity or service line.

The geographic spread and issuing-body mix reflect general health services procurement rather than vascular surgery: the Washington State Department of Transportation (occupational medical surveillance across 14 ferry system locations), City of Phoenix Retirement Office (disability medical evaluations), City of Long Beach (surgical procedure networks via Centers of Excellence), Harris County Juvenile Probation Department (emergency and specialty care), Collier County Board of County Commissioners (pharmacy benefit management), and County of Santa Clara Health System (temporary clinical staffing). This code shows no meaningful recent activity aligned with its stated scope and should be treated as a low-value target for vascular surgery service delivery.